About Shanghai Rendu Biotechnology Company

The company is an innovative enterprise focusing on the R&D, production and sales of RNA molecular diagnostic technology and products. Since its establishment, the company has been committed to developing and promoting RNA molecular diagnostic reagents and supporting automated equipment based on the RNA real-time fluorescence thermostatic amplification test (SAT) technology platform. The company's main business is R&D, production and sales of molecular diagnostic reagents and equipment integrated products based on the SAT technology platform, focusing on providing solutions for accurate diagnosis, effective prevention, control, and personalized diagnosis and treatment of pathogens in the fields of reproduction, respiration, digestion, hematogenesis, etc. The company's main products: reagent products, instrument products, third-party medical testing services. The company and its products were awarded the Ministry of Industry and Information Technology's third batch of “Little Giant” enterprises, Shanghai high-tech enterprises, Shanghai “specialized and new” small and medium-sized enterprises, patent work pilot and demonstration enterprises, Chinese medical device technology innovation enterprises, Ministry of Science and Technology's “Innovative Medical Device Product Catalogue (2018)”, Shanghai High-tech Achievement Transformation Project, “2019/2021 Shanghai Innovative Product Recommendation Catalogue”, third prize of Shanghai Science and Technology Award, Shanghai Enterprise Technology Center, National Intellectual Property Advantage Enterprise, Guangdong Science and Technology Progress Award, etc. An important award.